S. Dahlen (Stockholm, Sweden), H. M. Jansen (Amsterdam, The Netherlands)
A common intragenic marker of cysteinyl leukotrienes receptor-1 (T927C) does not correlate with a clinical response to the receptor's antagonist but is associated with peripheral blood eosinophilia
M. Sanak, V. Martin, L. Mastalerz, C. D. Funk, A. Szczeklik (Cracow, Poland; Philadelphia, United States Of America)
|  |
Effects of montelukast on tapering inhaled corticosteroids in patients with asthma
S. Nakajima, Y. Tohda, M. Fujimura, H. Taniguchi, K. Takagi, T. Igarashi, H. Yasuhara, K. Takahashi (Nara, Osaka, Ishikawa, Aichi, Tokyo, Japan)
| |
Efficacy and safety of montelukast sodium on adult bronchial asthma in a multicenter comparative double-blind clinical study with pranlukast hydrate
T. Miyamoto, S. Makino, S. Kitamura, K. Ito, J. Kabe, K. Mano, S. Nakajima, M. Yamakido, H. Yasuhara (Tokyo, Tochigi, Saitama, Kanagawa, Nara, Hiroshima, Japan)
| |
Montelukast and budesonide vs double dose budesonide in moderate asthma
Z. Yildirim, T. Ozlu, Y. Bulbul (Trabzon, Turkey)
| |
Clinical benefits and safety of long term treatment with montelukast (M) in patients with mild-to-moderate asthma
J. Mazurek, J. Wronska, R. Chazan (Warsaw, Poland)
| |
The effects of inhaled steroids, leukotriene receptor antagonists and theophylline on induced sputum cell counts, serum and sputum ECP levels in mild persistent asthma
I. E. Basyigit, F. Yildiz, S. K. Özkara, H. Boyaci, A. Ilgazli, O. Özkarakas (Kocaeli, Turkey)
| |
Activity of montelukast and metabolites against leukotrienes in human bronchus
H. Mechiche, E. Naline, C. Advenier, P. Birembaut, P. Devillier (Reims, Paris, France)
| |
Reducing the dose of inhaled corticosteroids (ICS) under therapy with montelukast in stable asthma: effects on lung function and inflammation
F. Kanniess, S. Janicki, M. Schleiss, R. A. Joerres, H. Magnussen (Grosshansdorf, Germany)
| |
Salmeterol/fluticasone propionate combination 50/100 μg bid is more effective than fluticasone propionate 100 μg bid plus montelukast 10 mg once daily in reducing exacerbations
M. Gold, R. Jõgi, P. G. H. Mulder, M. L. M. Akveld (Toronto, Canada; Tartu, Estonia; Rotterdam, The Netherlands; Uxbridge, United Kingdom)
| |
The effects of addition montelukast to inhaled steroids in the regular treatment of asthma
E. G. Yuksel, A. Erturk, D. Ediger, E. K. Uzaslan, N. Ozyardimci, R. O. Gozu, E. Ege, M. Karadag (Bursa, Turkey)
| |
The salmeterol/fluticasone propionate combination 50/100 μg bid is more effective than oral montelukast 10 mg od as a first line therapy in mild and moderate asthmatics
K. Rickard, P. M. Dorinsky, K. Knobil, P. Pepsin, M. L. M. Akveld (Research Triangle Park, United States Of America; Uxbridge, United Kingdom)
| |
Addition of leukotriene antagonists or long-acting β2-agonists to inhaled corticosteroid therapy in asthma treatment increases drug costs without decreasing service-related costs
G. Rachelefsky, C. Paramore, N. K. Leidy (Los Angeles, Bethesda, United States Of America)
| |
Low-dose fluticasone is superior to montelukast in asthma patients
K. Rickard, S. Goode-Sellers, L. Edwards, S. Srebro, C. Kalberg (Research Triangle Park, United States Of America)
| |
The effect of montelukast added to steroid on airway function as compared with steroid alone and placebo: a single blind, controlled study in acute asthma
A. Kara, A. Cilli, T. Ozdemir, C. Ogus (Antalya, Turkey)
| |
The fluticasone/salmeterol combination product is superior to montelukast as first-line asthma control
P. Dorinsky, C. Kalberg, P. Pepsin, A. Emmett, B. Bowers, K. Rickard (Research Triangle Park, United States Of America)
| |
Zafirlukast versus budesonide on bronchial reactivity in subjects with mild-persistent asthma
G. Riccioni, M. T. Guagnano, M. Castronuovo, M. De Benedictis, R. Della Vecchia (Chieti, Italy)
| |
Sulfidoleukotrienes (sLT) production in vitro by blood leucocytes in asthmatic patients treated with theophylline (T)
J. Mazurek, J. Wronska, I. Kraszewska, H. Grubek-Jaworska, R. Chazan (Warsaw, Poland)
| |
Possible neuropsychic adverse reactions with montelukast in childhood asthma
R. Nardelli, A. Dal Piaz, F. Rizzonelli, D. Sella (Trento, Italy)
| |